Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales264395401382476571
Operating income (EBITDA)-25,210456,011,696,1153
Operating profit (EBIT)-33,285,545,15,76115188
Pre-Tax Profit (EBT)-32,985,9-96,4---
Net income-32,985,9-18,1-10141,670,6
EPS ( $)-0,691,74-0,37-2,280,491,32
Dividend per Share ( $)------
Yield------
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt--246464426263
Finance154157----
Operating income (EBITDA)-25,210456,011,696,1153
Leverage
(Debt/EBITDA)
--4,39x40,1x4,43x1,71x
Capital Expenditure6,648,7610,49,0911,211,8
Book Value Per Share (BVPS)1,75 $4,06 $5,07 $3,26 $4,03 $5,81 $
Cash Flow per Share0,64 $-0,05 $-0,24 $1,84 $4,42 $5,25 $
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 1 540 M$ -
Entreprise Value (EV) 2 004 M$ 1 966 M$
Valuation 2014e 2015e
PER (Price / EPS) 62,7x
Capitalization / Revenue 4,03x 3,24x
EV / Revenue 5,24x 4,13x
EV / EBITDA 173x 20,5x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 1,51% 24,1%
operating Leverage (Delta EBIT / Delta Sales) -19,2x #
Net Margin (Net Profit / Revenue) -26,5% 8,74%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -2,27% 73,5%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   2,38% 2,35%
Cash Flow / Sales (Taux d'autofinancement) 24,2% 46,8%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 40,1x 4,43x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF